#######################
# Document Properties #
#######################
SET DOCUMENT Copyright   = "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved."
SET DOCUMENT Licenses    = "CC BY 4.0"
SET DOCUMENT ContactInfo = "charles.hoyt@scai.fraunhofer.de"

SET DOCUMENT Name        = "Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2."
SET DOCUMENT Version     = "1.0.0"
SET DOCUMENT Authors     = "Yojana Gadiya"
SET DOCUMENT Description = ""

##############
# Namespaces #
##############

# Namespaces hosted on https://github.com/pharmacome/conso
# --------------------------------------------------------
DEFINE NAMESPACE CHEBI          AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns"
# DEFINE NAMESPACE CONSO          AS URL "https://raw.githubusercontent.com/pharmacome/conso/3c93a65dc48e6786fe29ae55aa36cf9a902fe8c6/export/conso-names.belns"
# DEFINE NAMESPACE DRUGBANK       AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/drugbank-names.belns"
# DEFINE NAMESPACE DOID           AS URL "https://raw.githubusercontent.com/pharmacome/conso/c0c576e3d3ab9b25a3982251a4ee2fd7c49e1679/external/doid-names.belns"
# DEFINE NAMESPACE ECCODE         AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/ec-code.belns"
# DEFINE NAMESPACE EFO            AS URL "https://raw.githubusercontent.com/pharmacome/conso/5d2c2ea6f7112421cc8089a3f021a75ab60bb373/external/efo-names.belns"
# DEFINE NAMESPACE FB             AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/fb-names.belns"
DEFINE NAMESPACE HGNC           AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns"
DEFINE NAMESPACE HGNCGENEFAMILY AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc.genefamily-names.belns"
# DEFINE NAMESPACE HP             AS URL "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/hp-names.belns"
DEFINE NAMESPACE GO             AS URL "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/go-names.belns"
# DEFINE NAMESPACE INTERPRO       AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/interpro-names.belns"
DEFINE NAMESPACE MESH           AS URL "https://raw.githubusercontent.com/pharmacome/conso/f02c6ad4a4791a8ed45448513b9de8c8f1b00c87/external/mesh-names.belns"
# DEFINE NAMESPACE MGI            AS URL "https://raw.githubusercontent.com/pharmacome/conso/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/mgi-names.belns"
# DEFINE NAMESPACE MIRBASE        AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/mirbase-names.belns"
# DEFINE NAMESPACE NCBIGENE       AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/ncbigene.belns"
# DEFINE NAMESPACE PFAM           AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/pfam-names.belns"
# DEFINE NAMESPACE RGD            AS URL "https://raw.githubusercontent.com/pharmacome/conso/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/rgd-names.belns"

# Namespaces hosted on https://github.com/sorgerlab/famplex
# ---------------------------------------------------------
# DEFINE NAMESPACE FPLX           AS URL "https://raw.githubusercontent.com/sorgerlab/famplex/d9ec0526c20795146a9a6aef17496efe1a36cac6/export/famplex.belns"

# Namespaces defined with regular expressions
# -------------------------------------------
# DEFINE NAMESPACE DBSNP          AS PATTERN "rs[0-9]+"
# DEFINE NAMESPACE TAXONOMY       AS PATTERN "^\d+$"
# DEFINE NAMESPACE UNIPROT        AS PATTERN "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\.\d+)?$"
 DEFINE NAMESPACE PUBCHEM        AS PATTERN "^\d+$"

###############
# Annotations #
###############

# Annotations defined with regular expressions
# --------------------------------------------
DEFINE ANNOTATION Species       AS PATTERN "^\d+$"

# Annotations hosted on https://arty.scai.fraunhofer.de/artifactory/bel/annotation
# --------------------------------------------------------------------------------
# DEFINE ANNOTATION Anatomy       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno"
 DEFINE ANNOTATION CellLine      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno"
# DEFINE ANNOTATION CellStructure AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno"
# DEFINE ANNOTATION Cell          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno"
# DEFINE ANNOTATION Confidence    AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno"
# DEFINE ANNOTATION Disease       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno"
# DEFINE ANNOTATION Gender        AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno"
# DEFINE ANNOTATION MeSHAnatomy   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
# DEFINE ANNOTATION MeSHDisease   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
# DEFINE ANNOTATION Subgraph      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno"
# DEFINE ANNOTATION TextLocation  AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"

##############
# Statements #
##############
SET Citation = {"PubMed", "10887109"}

SET Evidence = "The high expression of CD33 on myeloid progenitors and its regulation during development suggests a critical role for this siglec in the control of myelopoiesis."
path(MESH:"Growth and Development") -> p(HGNC:CD33,loc(MESH:"Myeloid Progenitor Cells"))
path(MESH:"Growth and Development") reg p(HGNC:CD33)
p(HGNC:CD33) reg path(MESH:Myelopoiesis)

SET Evidence = "On co-ligation with activation receptors, these proteins become tyrosine phosphorylated, and recruit one or more of the protein tyrosine phosphatases SHP-1, SHP-2, and/or the inositol phosphatase, SHIP.[33]"
#CD22, FcγRIIB, KIR, PIR-B, CD33 receptors
complex(complex(GO:"receptor complex"),p(HGNC:CD22)) -> p(HGNC:CD22,pmod(Ph,Tyr))
complex(complex(GO:"receptor complex"),p(HGNC:FCGR2B)) -> p(HGNC:FCGR2B,pmod(Ph,Tyr))
complex(complex(GO:"receptor complex"),p(HGNCGENEFAMILY:"Killer cell immunoglobulin like receptors")) -> p(HGNCGENEFAMILY:"Killer cell immunoglobulin like receptors",pmod(Ph,Tyr))
complex(complex(GO:"receptor complex"),p(HGNC:PILRB)) -> p(HGNC:PILRB,pmod(Ph,Tyr))
complex(complex(GO:"receptor complex"),p(HGNC:CD33)) -> p(HGNC:CD33,pmod(Ph,Tyr,340),pmod(Ph,Tyr,358))
p(HGNC:CD22,pmod(Ph,Tyr)) -> tloc(p(HGNC:PTPN6),fromLoc(GO:"extracellular region"),toLoc(GO:cytoplasm))
p(HGNC:CD22,pmod(Ph,Tyr)) -> tloc(p(HGNC:PTPN11),fromLoc(GO:"extracellular region"),toLoc(GO:cytoplasm))
p(HGNC:CD22,pmod(Ph,Tyr)) -> tloc(p(HGNC:INPP5D),fromLoc(GO:"extracellular region"),toLoc(GO:cytoplasm))
p(HGNC:FCGR2B,pmod(Ph,Tyr)) -> tloc(p(HGNC:PTPN6),fromLoc(GO:"extracellular region"),toLoc(GO:cytoplasm))
p(HGNC:FCGR2B,pmod(Ph,Tyr)) -> tloc(p(HGNC:PTPN11),fromLoc(GO:"extracellular region"),toLoc(GO:cytoplasm))
p(HGNC:FCGR2B,pmod(Ph,Tyr)) -> tloc(p(HGNC:INPP5D),fromLoc(GO:"extracellular region"),toLoc(GO:cytoplasm))
p(HGNCGENEFAMILY:"Killer cell immunoglobulin like receptors",pmod(Ph,Tyr)) -> tloc(p(HGNC:PTPN6),fromLoc(GO:"extracellular region"),toLoc(GO:cytoplasm))
p(HGNCGENEFAMILY:"Killer cell immunoglobulin like receptors",pmod(Ph,Tyr)) -> tloc(p(HGNC:PTPN11),fromLoc(GO:"extracellular region"),toLoc(GO:cytoplasm))
p(HGNCGENEFAMILY:"Killer cell immunoglobulin like receptors",pmod(Ph,Tyr)) -> tloc(p(HGNC:INPP5D),fromLoc(GO:"extracellular region"),toLoc(GO:cytoplasm))
p(HGNC:PILRB,pmod(Ph,Tyr)) -> tloc(p(HGNC:PTPN6),fromLoc(GO:"extracellular region"),toLoc(GO:cytoplasm))
p(HGNC:PILRB,pmod(Ph,Tyr)) -> tloc(p(HGNC:PTPN11),fromLoc(GO:"extracellular region"),toLoc(GO:cytoplasm))
p(HGNC:PILRB,pmod(Ph,Tyr)) -> tloc(p(HGNC:INPP5D),fromLoc(GO:"extracellular region"),toLoc(GO:cytoplasm))
p(HGNC:CD33,pmod(Ph,Tyr,340),pmod(Ph,Tyr,358)) -> tloc(p(HGNC:PTPN6),fromLoc(GO:"extracellular region"),toLoc(GO:cytoplasm))
p(HGNC:CD33,pmod(Ph,Tyr,340),pmod(Ph,Tyr,358)) -> tloc(p(HGNC:PTPN11),fromLoc(GO:"extracellular region"),toLoc(GO:cytoplasm))
p(HGNC:CD33,pmod(Ph,Tyr,340),pmod(Ph,Tyr,358)) -> tloc(p(HGNC:INPP5D),fromLoc(GO:"extracellular region"),toLoc(GO:cytoplasm))

SET Evidence = "The recruited phosphatases then dephosphorylate cytoplasmic substrates otherwise involved in cellular activation."
#phosphatases - SHIP,SHP-1, SHP-2
p(HGNC:PTPN6) -| p(MESH:Proteins,pmod(Ph))
p(HGNC:PTPN11) -| p(MESH:Proteins,pmod(Ph))
p(HGNC:INPP5D) -| p(MESH:Proteins,pmod(Ph))
p(MESH:Proteins) -- bp(GO:"cell activation")

SET CellLine = "U937"

SET Evidence = "Figure 1 shows that pervanadate treatment resulted in tyrosine phosphorylation of CD33 (upper panel)."
#in U937 cells
#24978557 - pervanadate
a(PUBCHEM:24978557) -> p(HGNC:CD33,pmod(Ph))

SET Evidence = "The protein tyrosine phosphatases SHP-1 and SHP-2 are known to be tyrosine phosphorylated [35,36] and bind phosphotyrosine motifs in inhibitory receptors, suggesting that they could be one or more of the phosphoproteins co-precipitating with CD33."
p(HGNC:PTPN6) -> complex(p(HGNC:PTPN6,pmod(Ph,Tyr)),p(HGNC:CD33,pmod(Ph)))
p(HGNC:PTPN11) -> complex(p(HGNC:PTPN11,pmod(Ph,Tyr)),p(HGNC:CD33,pmod(Ph)))

UNSET CellLine

SET CellLine = "HEK293T"

SET Evidence = "These experiments determined that Lck, but not Syk or Zap70, was capable of mediating phosphorylation of CD33 in vivo (Figure 2A)."
#in HEk293T cells
act(p(HGNC:LCK),ma(kin)) -> p(HGNC:CD33,pmod(Ph))
act(p(HGNC:SYK),ma(kin)) cnc p(HGNC:CD33,pmod(Ph))
act(p(HGNC:ZAP70),ma(kin)) cnc p(HGNC:CD33,pmod(Ph))
act(p(HGNC:LCK,var("p.Lys273Arg")),ma(kin)) cnc p(HGNC:CD33,pmod(Ph))
act(p(HGNC:SYK,var("p.Lys395Arg")),ma(kin)) cnc p(HGNC:CD33,pmod(Ph))
act(p(HGNC:ZAP70,var("p.Lys369Arg")),ma(kin)) cnc p(HGNC:CD33,pmod(Ph))

SET Evidence = "These data are consistent with the ability of Src-family kinases to efficiently phosphorylate both biliary glycoprotein and platelet and endothelial cell adhesion molecule-1 (PECAM-1), because the amino acids flanking the cytoplasmic tyrosines of these two receptors are similar to those of CD33.[2,40,41]"
p(HGNCGENEFAMILY:"Src family tyrosine kinases") -> p(HGNC:PECAM1,pmod(Ph))

SET Evidence = "Even though each of the mutant receptors was expressed in 293T cells as detected by flow cytometry (data not shown) and immunoblotting of parallel samples with anti-CD33, we detected significant tyrosine phosphorylation only of wild-type CD33 and CD33 Y358F (Figure 2B, lanes 2 and 4)."
#mutant - Y358F, Y340F, Y358F/Y340F
#Ph by Lck
act(p(HGNC:LCK),ma(kin)) -> p(HGNC:CD33,pmod(Ph,Tyr))
act(p(HGNC:LCK),ma(kin)) -> p(HGNC:CD33,var("p.Tyr358Phe"),pmod(Ph,Tyr))
act(p(HGNC:LCK),ma(kin)) cnc p(HGNC:CD33,var("p.Tyr340Phe"),pmod(Ph,Tyr))
act(p(HGNC:LCK),ma(kin)) cnc p(HGNC:CD33,var("p.Tyr358Phe"),var("p.Tyr340Phe"),pmod(Ph,Tyr))

SET Evidence = "These data suggest that Lck phosphorylates primarily Y340 of CD33."
act(p(HGNC:LCK),ma(kin)) -> p(HGNC:CD33,pmod(Ph,Tyr,340))

SET Evidence = "Interestingly, the study of PECAM-1 suggested that Lck primarily phosphorylated tyrosine 686, the distal tyrosine of PECAM-1, despite the fact that the sequence surrounding this tyrosine 686 of PECAM, TETVY686SEIR, is most homologous to the distal ITIM of CD33, TSTEY358SEVR. [41] "
act(p(HGNC:LCK),ma(kin)) -> p(HGNC:PECAM1,pmod(Ph,Tyr,686))

UNSET CellLine

SET Evidence = "Phosphorylated tyrosines in these motifs could serve as docking sites for the tyrosine phosphatases SHP-1 and/or SHP-2. CD33 could then function as an inhibitory receptor, regulating the phosphorylation of an activating counterpart or other proteins associated with macrophage activation."
p(HGNC:PTPN6) -> p(HGNC:CD33,pmod(Ph,Tyr,340))
p(HGNC:PTPN6) -> p(HGNC:CD33,pmod(Ph,Tyr,358))
p(HGNC:PTPN11) -> p(HGNC:CD33,pmod(Ph,Tyr,340))
p(HGNC:PTPN11) -> p(HGNC:CD33,pmod(Ph,Tyr,358))
p(HGNC:CD33,pmod(Ph,Tyr,340)) -> complex(p(HGNC:PTPN6),p(HGNC:CD33))
p(HGNC:CD33,pmod(Ph,Tyr,358)) -> complex(p(HGNC:PTPN6),p(HGNC:CD33))
p(HGNC:CD33,pmod(Ph,Tyr,340)) -> complex(p(HGNC:PTPN11),p(HGNC:CD33))
p(HGNC:CD33,pmod(Ph,Tyr,358)) -> complex(p(HGNC:PTPN11),p(HGNC:CD33))
p(HGNC:CD33,pmod(Ph,Tyr,340)) reg bp(GO:"macrophage activation")
p(HGNC:CD33,pmod(Ph,Tyr,358)) reg bp(GO:"macrophage activation")

SET Evidence = "Western blot analysis of the immunoprecipitates showed that the phosphatases, SHP-1 (Figure 3) and SHP-2 (Figure 4) co-immunoprecipitated with phosphorylated CD33. Similar analysis using anti-SHIP demonstrated no interaction between CD33 and SHIP (data not shown)."
#Mo7e, THP-1, and U937 cells
SET CellLine = {"U937","THP-1"}
p(HGNC:PTPN6) -> complex(p(HGNC:PTPN6),p(HGNC:CD33,pmod(Ph)))
p(HGNC:PTPN11) -> complex(p(HGNC:PTPN11),p(HGNC:CD33,pmod(Ph)))
p(HGNC:INPP5D) -|  complex(p(HGNC:INPP5D),p(HGNC:CD33,pmod(Ph)))
UNSET CellLine

SET Evidence = "Figure 5 shows that the phosphorylated Y340 peptide bound both SHP-1 and SHP-2."
p(HGNC:CD33,pmod(Ph,Tyr,340)) -> complex(p(HGNC:CD33),p(HGNC:PTPN6))
p(HGNC:CD33,pmod(Ph,Tyr,340)) -> complex(p(HGNC:CD33),p(HGNC:PTPN11))

SET Evidence = "In marked contrast, the phosphorylated Y358 peptide bound SHP-2 well but did not bind significant amounts of SHP-1."
p(HGNC:CD33,pmod(Ph,Tyr,358)) -> complex(p(HGNC:CD33),p(HGNC:PTPN11))
p(HGNC:CD33,pmod(Ph,Tyr,358)) cnc complex(p(HGNC:CD33),p(HGNC:PTPN6))

SET Evidence = "These authors found that a change in the amino acid −2 relative to the phosphotyrosine from valine to either isoleucine or leucine did not show significant difference in the phosphatase activity of the peptides."
#in KIR ITIM for SHP-1 activity
p(HGNCGENEFAMILY:"Killer cell immunoglobulin like receptors",pmod(Ph,Tyr),var("p.Val?Ile")) cnc act(p(HGNC:PTPN6),ma(GO:"phosphatase activity"))
p(HGNCGENEFAMILY:"Killer cell immunoglobulin like receptors",pmod(Ph,Tyr),var("p.Val?Leu")) cnc act(p(HGNC:PTPN6),ma(GO:"phosphatase activity"))

SET Evidence = "In contrast, changing the amino acid at +3 from leucine to valine resulted in a significantly lower induction of SHP-1 phosphatase activity.[42]"
#in CD33
p(HGNC:CD33,pmod(Ph,Tyr,340),var("p.Leu343Val")) -| act(p(HGNC:PTPN6),ma(GO:"phosphatase activity"))

SET Evidence = "The presence of valine at +3 of Y358 could, therefore, decrease the ability of this phosphopeptide to bind SHP-1."
p(HGNC:CD33,pmod(Ph,Tyr,358),var("p.Leu361Val")) -| complex(p(HGNC:CD33),p(HGNC:PTPN6))

SET Evidence = "Detailed study of SHP-1 has demonstrated that phosphopeptide binding to the amino SH2 domain is required for significant activation of phosphatase activity. n contrast, binding of the carboxyl SH2 domain may serve primarily in the physical recruitment of the enzyme.[45]"
#amino terminal
act(complex(p(MESH:"Phosphopeptides"),p(HGNC:PTPN6)),ma(GO:"SH2 domain binding")) -> act(p(HGNC:PTPN6),ma(GO:"phosphatase activity"))
#carboxyl terminal
act(complex(p(MESH:"Phosphopeptides"),p(HGNC:PTPN6)),ma(GO:"SH2 domain binding")) -> p(HGNC:PTPN6)


SET Evidence = " Like Figure 5, this analysis demonstrated the ability of Y340, but not Y358, to bind SHP-1."
SET CellLine = "U937"
p(HGNC:CD33,pmod(Ph,Tyr,340)) -> complex(p(HGNC:CD33,pmod(Ph,Tyr,340)),p(HGNC:PTPN6))
p(HGNC:CD33,pmod(Ph,Tyr,358)) -| complex(p(HGNC:CD33,pmod(Ph,Tyr,358)),p(HGNC:PTPN6))
UNSET CellLine

SET Evidence = "Interestingly, mutation of the amino-terminal SH2 domain (SHP-1 R30K) ablated binding of SHP-1 to Y340, suggesting this SH2 domain as the primary site of interaction between the receptor and the phosphatase. The strong binding of SHP-1 via its amino terminal SH2 domain suggests the interaction between CD33 and SHP-1 would result in significant activation of SHP-1.[45] "
SET CellLine = "HEK293T"
p(HGNC:PTPN6,var("p.Arg30Lys")) -| complex(p(HGNC:CD33,pmod(Ph,Tyr,340)),p(HGNC:PTPN6))
complex(p(HGNC:CD33),p(HGNC:PTPN6)) -> act(p(HGNC:PTPN6))
complex(p(HGNC:CD33),p(HGNC:PTPN6)) -> act(p(HGNC:PTPN6))
p(HGNC:PTPN6,var("p.Arg136Lys")) -> complex(p(HGNC:CD33,pmod(Ph,Tyr,340)),p(HGNC:PTPN6))
p(HGNC:CD33,pmod(Ph,Tyr,358)) -| complex(p(HGNC:CD33,pmod(Ph,Tyr,358)),p(HGNC:PTPN6,var("p.Arg30Lys")))
p(HGNC:CD33,pmod(Ph,Tyr,358)) -| complex(p(HGNC:CD33,pmod(Ph,Tyr,358)),p(HGNC:PTPN6,var("p.Arg139Lys")))
UNSET CellLine

SET CellLine = "U937"

SET Evidence = "Cross-linking of control antibody or CD33 alone resulted in no increase in [Ca++]i. In contrast, cross-linking of CD64 resulted in robust mobilization of intracellular calcium as demonstrated by the increase in [Ca++]i (Figure 7).Co-cross-linking of CD64 with CD33, however, resulted in diminished calcium mobilization as compared with cross-linking of CD64 alone."
#control - Igg
p(HGNC:CD33) cnc a(CHEBI:"calcium(2+)")
complex(p(HGNC:CD33),p(HGNC:FCGR1A),p(HGNC:IFNG)) -| a(CHEBI:"calcium(2+)")
complex(p(HGNC:FCGR1A),p(HGNC:IFNG)) -> a(CHEBI:"calcium(2+)")

SET Evidence = "Anti-CD33 co-cross-linking inhibited CD64-mediated increases in [Ca++]i after infection with pSC65-containing virus and after expression of kinase dead Zap70 even though expression of dead Zap70 was evident by Western blotting (data not shown)."
p(HGNC:CD33) -- act(p(HGNC:FCGR1A))
p(HGNC:FCGR1A) -> bp(GO:"calcium ion import")

SET Evidence = "In addition, to preventing CD33-mediated inhibition, the SHP-1 C453S infection relieved the basal control of CD64-mediated calcium mobilization, resulting in increased [Ca++]i following CD64 cross-linking. "
p(HGNC:PTPN6,var("p.Cys453Ser")) -> act(p(HGNC:CD33))
p(HGNC:PTPN6,var("p.Cys453Ser")) -> act(p(HGNC:FCGR1A))
p(HGNC:PTPN6,var("p.Cys453Ser")) -> bp(GO:"calcium ion import")
